e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Effects of pulmonary rehabilitation other than improving exercise capacity
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Novel approaches for targeting muscle wasting in COPD
M. Steiner (Leicester (Leicestershire), United Kingdom)
Source:
International Congress 2019 – Effects of pulmonary rehabilitation other than improving exercise capacity
Session:
Effects of pulmonary rehabilitation other than improving exercise capacity
Session type:
Symposium
Number:
225
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Steiner (Leicester (Leicestershire), United Kingdom). Novel approaches for targeting muscle wasting in COPD. International Congress 2019 – Effects of pulmonary rehabilitation other than improving exercise capacity
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
The prevalence of Obstructive Sleep Apnea (OSA) in patients recovering from COVID-19
ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment
Related content which might interest you:
Comparison of different methods to screen skeletal muscle function in chronic wasting diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 22s
Year: 2001
The relevance of respiratory muscle dysfunction and novel treatment options in COPD
Source: International Congress 2017 – PG18 Targeting the locomotor and respiratory muscles in chronic obstructive pulmonary disease: novel interventional tools and rehabilitation strategies
Year: 2017
Unbiased analysis of skeletal muscle molecular responses upon pulmonary rehabilitation in advanced COPD
Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2018
Skeletal muscle inflammatory markers in COPD patients with muscle wasting
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
Novel diagnostic tools and interventions for COPD locomotor and respiratory muscle dysfunction
Source: International Congress 2017 – PG18 Targeting the locomotor and respiratory muscles in chronic obstructive pulmonary disease: novel interventional tools and rehabilitation strategies
Year: 2017
Permeabilized skeletal muscle fiber technique: a tool to unravel energy metabolism dysfunction in myopathy during chronic lung diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 393s
Year: 2003
Role of exosomal microRNA in driving skeletal muscle wasting in COPD
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015
Impaired coordination of skeletal muscle protein turnover signalling in sarcopenic COPD patients
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
The association of vitamine D deficiency and skeletal muscle dysfunction in COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Ultrasound assessment of quadriceps muscle in COPD patients: Functional and clinical implications
Source: International Congress 2016 – Best abstracts in exercise capacity and testing in chronic lung diseases
Year: 2016
Impaired myogenesis in the quadriceps muscle of cachectic COPD patients
Source: International Congress 2014 – Respiratory pathophysiology: mechanisms of alteration of lung, respiratory and peripheral muscle function
Year: 2014
New modalities of nutritional aspects of pulmonary disease in the elderly
Source: Eur Respir Mon; 2009: 43: 240–255
Year: 2009
Investigating circulating microRNAs as potential biomarkers of quadriceps weakness in COPD
Source: Annual Congress 2011 - Skeletal muscle weakness in COPD: physical (in)activity and biological markers
Year: 2011
Evaluation of anti-aging klotho protein in COPD rehabilitation
Source: International Congress 2016 – Latest insights into functional capacity and muscle weakness in chronic lung diseases
Year: 2016
The effect of COPD on muscle structure and function
Source: Annual Congress 2006 - COPD: a systemic disease affecting the muscles
Year: 2006
Relationship between the tissue depletion pattern and muscle mass, muscle strength and inflammation in COPD patients
Source: Annual Congress 2006 - COPD and systemic inflammation
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept